BG45(cas:926259-99-6) is a potent and selective HDAC3 inhibitor inhibitor with selectivity for HDAC3 (IC50 = 289 nM) over HDAC1, 2. BG45 did not inihibit HDAC6. BG45 signigicantly inhibited tumor growth in a mouse model of multiple myeloma either alone and synergistically in combination with bortezomib. HDAC3 represents a promising therapeutic target, and validate a prototype novel HDAC3 inhibitor BG45 in MM.
中文别名 | BG45(cas:926259-99-6);HDAC3 inhibitor;HDAC3抑制剂 |
英文别名 | BG45,926259-99-6 |
CAS号 | 926259-99-6 |
SMILES | O=C(C1=NC=CN=C1)NC2=CC=CC=C2N |
Inchi | InChI=1S/C11H10N4O/c12-8-3-1-2-4-9(8)15-11(16)10-7-13-5-6-14-10/h1-7H,12H2,(H,15,16) |
InchiKey | LMWPVSNHKACEKW-UHFFFAOYSA-N |
分子式 Formula | C11H10N4O |
分子量 Molecular Weight | 214.22 |
闪点 FP | 146.7±25.1 ℃ |
沸点 Boiling point | 319.0±32.0 ℃ at 760 mmHg |
Polarizability极化度 | 24.3±0.5 10-24cm3 |
密度 Density | 1.4±0.1 g/cm3 |
蒸汽压 Vapor Pressure | 0.0±0.7 mmHg at 25℃ |
溶解度Solubility | DMSO (Slightly), Methanol (Slightly) |
性状 | 固体粉末,Power |
储藏条件 Storage conditions | -20℃ 3 years年 4℃ 2 years年 / In solvent溶液中:-80℃ 6 months月 -20℃ 1 month月 |